Skip to main content
About
Management
Board of Directors
Scientific Advisory Board
Business Development
Contact Us
Pipeline
Programs
KRAS G12C Inhibitor (MRTX849)
Sitravatinib (MGCD516)
Posters/Publications
Clinical Trials
Mirati Sponsored Trials
Collaboration Trials
Expanded Access Policy
(Compassionate Use)
Careers
Mission & Values
Investors
Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Financials & Filings
Corporate Governance
Investor FAQs
IR Contact
Emails Alerts
News Releases
Normal
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2/25/2021
Mirati Therapeutics Reports Fourth Quarter And Full-Year 2020 Financial Results And Recent Corporate Updates
2/18/2021
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
2/10/2021
MD Anderson And Mirati Therapeutics Announce KRAS Strategic Research And Development Collaboration In Solid Tumors
2/04/2021
Mirati Therapeutics To Present At Guggenheim Healthcare Talks 2021 Oncology Days
1/04/2021
Mirati Therapeutics To Present At The 39th Annual J.P. Morgan Healthcare Conference